BCDA · BioCardia, Inc.

NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD

BioCardia Inc (BCDA)

NASDAQ NMS - GLOBAL MARKET Biotechnology
Move probability → Options chain →
$0.98 -0.06 (-5.92%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE $0.98
$0.98 $1.00
52-WEEK RANGE $0.98
$0.75 $1.80

What's happening

Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.

Key Statistics

Market Cap$15.3M
P/E (TTM1)—
EPS2 (TTM)$-0.80
Div Yield—
Beta30.63
Volume342
Open1.00
Prev Close1.04
Bid / Ask0.85 / 1.21
Next Earnings 2026-11-11

Analyst Recommendations

Strong buy 2 Buy 5 Hold 1 Sell 0 Strong sell 0

Aggregate ratings for 2026-10-01 (8 analysts polled by Finnhub) — consensus count.

Performance Overview (Trailing returns vs S&P 500 benchmark)

YTD RETURN
BCDA -28.20%
vs S&P 500 -40.60%
1-YEAR RETURN
BCDA -38.10%
vs S&P 500 -53.47%
6-MONTH RETURN
BCDA -24.58%
3-MONTH RETURN
BCDA -0.81%

Valuation Measures & Ratios

Enterprise Value4$11.9M
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)37.23
Price / Book76.84
EV4 / Revenue27.68
EV4 / EBITDA5.10
Profit Margin-1985.85%
Operating Margin-1997.45%
Return on Equity (ROE8)-221.68%
Return on Assets (ROA9)-261.66%
Avg Volume (3M)461,570
Quarterly history (5 periods)
Measure Jun '26Mar '26Sep '25Jun '25Mar '25
Market cap — $12.5M — $10.3M $11.6M
P/E — -1.47 — -1.27 -1.39
Price/Book — -11.76 — -5.49 -7.65
EV/EBITDA — -1.36 — — —
ROE — 797.65% — 431.81% 550.13%
ROA — -496.67% — -389.85% -386.06%

Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).

Glossary — what these abbreviations mean
1. TTM
Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
2. EPS
Earnings per share — net income divided by diluted shares outstanding.
3. Beta
A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
4. EV (Enterprise Value)
Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
5. Forward P/E
Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
6. PEG Ratio
P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
7. Price / Book
Share price divided by book value (assets minus liabilities) per share.
8. ROE
Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
9. ROA
Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
10. MRQ
Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
11. YoY
Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.

Short Interest

Shares Short619,162
Change from Prior Settlement-28.31%
% of Float—
Days to Cover (Short Ratio)1.27

Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.

Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.

Price history

Events

Drag horizontally to zoom into a section; use Reset view to restore all observations.

Technical signal summary

Calculating from the latest year of daily price history…

Calculating…
Show Technical Analysis Breakdown ▾ 10 Indicators

Not investment advice — read several signals together.

Indicators None active

Add lines over the price chart or a panel below it. Your choices are saved on this device.

Starter sets
Trend
Oscillators
Volume/volatility
Loading chart…

History limited by data provider; markers are heuristics, not signals.

Peer and sector context

No reviewed peer group is available for this symbol.

Balanced evidence

A deterministic summary of sourced facts—not an AI verdict.

Potential strengths

  • Latest SEC filing is Form 4, filed 2026-10-20; review it for current changes and risks. SEC EDGAR ↗

Potential concerns

Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.

Financials

Income statement

Line item Jun '26Mar '26Sep '25Jun '25Mar '25Sep '24Jun '24Mar '24
Revenue — — — — — — — —
Gross profit — — — — — — — —
Operating income -$1.6M -$2.3M -$1.5M -$2.1M -$2.7M -$1.8M -$1.6M -$2.3M
Net income -$1.6M -$2.3M -$1.5M -$2.0M -$2.7M -$1.7M -$1.6M -$2.3M
EPS (diluted) — $-0.21 — $-0.40 $-0.59 — — —
EPS (basic) $-0.13 $-0.21 $-0.24 $-0.40 $-0.59 $-0.61 $-0.88 $-1.35

Balance sheet

Line item Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24
Total assets $4.8M $1.7M $3.4M $6.1M $2.1M $2.2M $3.7M $6.3M
Total liabilities $2.1M $2.8M $2.5M $3.5M $4.0M $3.7M $2.9M $3.5M
Stockholders' equity $2.7M -$1.1M $895.0K $2.6M -$1.9M -$1.5M $837.0K $2.8M
Total current assets $4.3M $1.1M $2.7M $5.4M $1.2M $1.2M $2.6M $5.1M
Total current liabilities $2.1M $2.8M $2.4M $3.3M $3.6M $3.2M $2.3M $2.8M
Cash & equivalents $4.1M $951.0K $2.5M $5.3M $980.0K $949.0K $2.4M $4.9M

Cash flow

Line item Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24
Operating cash flow -$1.7M -$1.7M -$2.5M -$1.7M -$1.6M -$1.6M -$2.4M -$2.6M
Investing cash flow $0 -$3.0K -$6.0K $0 -$1.0K $0 -$1.0K -$2.0K
Financing cash flow $4.9M $117.0K -$288.0K $6.0M $1.7M $196.0K -$125.0K $6.1M
Free cash flow -$1.7M -$1.7M -$2.5M -$1.7M -$1.6M -$1.6M -$2.4M -$2.6M
Capital expenditures $0 $3.0K $6.0K $0 $1.0K $0 $1.0K $2.0K
Depreciation & amortization $3.0K $3.0K $3.0K $4.0K $5.0K $12.0K $15.0K $16.0K

Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.

Institutional holders

SEC Form 13F filers holding BCDA as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.

Institutional ownership is not available for this symbol right now.

Insider activity

Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.

Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-06-17 to 2026-10-16

Recent transactions

  • Insiders have net bought 145,700 shares over the last 182 days, across 19 purchases and 0 sales.
  • Most recent: Altman Peter (President and CEO) — Open market purchase of 300 shares on 2026-10-16.

Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.

Insider purchases & sales, last 6 months

Purchases (open market)145,700 sh(19 txns)
Sales (open market)0 sh(0 txns)
Net Shares+145,700

Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.

Insider roster

NameTitleMost Recent TransactionDateShares
Altman PeterPresident and CEOOpen market purchase2026-10-16300
McClung DavidChief Financial OfficerTax withholding2026-07-0223,125
GILLIS EDWARD MSenior Vice President, DevicesTax withholding2026-07-0217,269
STERTZER SIMON HDirectorOpen market purchase2026-06-2339,000

Recent transactions

DateInsiderTitleTransactionSharesPrice
2026-10-16Altman PeterPresident and CEOOpen market purchase 300$0.95
2026-10-15Altman PeterPresident and CEOOpen market purchase 200$0.95
2026-09-29Altman PeterPresident and CEOOpen market purchase 1,000$1.03
2026-09-23Altman PeterPresident and CEOOpen market purchase 1,900$1.05
2026-09-03Altman PeterPresident and CEOOpen market purchase 800$1.09
2026-08-17Altman PeterPresident and CEOOpen market purchase 5,400$0.93
2026-08-13Altman PeterPresident and CEOOpen market purchase 1,900$0.92
2026-07-29Altman PeterPresident and CEOOpen market purchase 5,000$0.78
2026-07-17Altman PeterPresident and CEOOpen market purchase 500$0.83
2026-07-15Altman PeterPresident and CEOOpen market purchase 1,500$0.86
2026-07-14Altman PeterPresident and CEOOpen market purchase 2,800$0.88
2026-07-10Altman PeterPresident and CEOOpen market purchase 1,000$0.94
2026-07-09Altman PeterPresident and CEOOpen market purchase 1,000$0.90
2026-07-08Altman PeterPresident and CEOOpen market purchase 5,500$0.97
2026-07-08Altman PeterPresident and CEOOpen market purchase 5,400$0.96
2026-07-02Altman PeterPresident and CEOTax withholding 54,606$1.24
2026-07-02McClung DavidChief Financial OfficerTax withholding 23,125$1.24
2026-07-02GILLIS EDWARD MSenior Vice President, DevicesTax withholding 17,269$1.24
2026-06-29Altman PeterPresident and CEOGrant / award 110,625$1.20
2026-06-29McClung DavidChief Financial OfficerGrant / award 60,483$1.20
2026-06-29GILLIS EDWARD MSenior Vice President, DevicesGrant / award 39,521$1.20
2026-06-23STERTZER SIMON HDirectorOpen market purchase 39,000$1.00
2026-06-22STERTZER SIMON HDirectorOpen market purchase 70,200$0.92
2026-06-18Altman PeterPresident and CEOOpen market purchase 800$0.96
2026-06-17Altman PeterPresident and CEOOpen market purchase 1,500$0.85

Recent SEC filings

Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.

Source: SEC EDGAR submissions · updated 2026-10-21 22:57 UTC

FiledFormReport periodOfficial filing
2026-10-2042026-10-15 View on SEC.gov →
2026-10-198-K2026-10-19 View on SEC.gov →
2026-10-078-K2026-10-07 View on SEC.gov →
2026-10-018-K2026-10-01 View on SEC.gov →
2026-09-3042026-09-29 View on SEC.gov →
2026-09-2342026-09-23 View on SEC.gov →
2026-09-238-K2026-09-23 View on SEC.gov →
2026-09-218-K2026-09-21 View on SEC.gov →
2026-09-108-K2026-09-10 View on SEC.gov →
2026-09-0442026-09-03 View on SEC.gov →
2026-08-248-K2026-08-24 View on SEC.gov →
2026-08-218-K2026-08-19 View on SEC.gov →

Headlines about BCDA (BioCardia, Inc.). Links open the publisher — we don’t host full articles.

SEC filings ↓

← Back to the full dashboard · My watchlist